These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 38722276)
1. Topical platelet-rich plasma as a possible treatment for olfactory dysfunction-A randomized controlled trial. Duffy A; Naimi B; Garvey E; Hunter S; Kumar A; Kahn C; Farquhar D; D'Souza G; Rawson N; Dalton P; Toskala E; Rabinowitz M; Rosen M; Nyquist G; Rosen D Int Forum Allergy Rhinol; 2024 Sep; 14(9):1455-1464. PubMed ID: 38722276 [TBL] [Abstract][Full Text] [Related]
2. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction. Lechien JR; Le Bon SD; Saussez S Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Platelet-Rich Plasma for COVID-19-Related Olfactory Dysfunction: A Controlled Study. Lechien JR; Saussez S; Vaira LA; De Riu G; Boscolo-Rizzo P; Tirelli G; Michel J; Radulesco T Otolaryngol Head Neck Surg; 2024 Jan; 170(1):84-91. PubMed ID: 37522295 [TBL] [Abstract][Full Text] [Related]
4. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial. Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615 [TBL] [Abstract][Full Text] [Related]
5. Platelet-rich plasma for the treatment of COVID-19 related olfactory dysfunction: a systematic review. AlRajhi B; Alrodiman OA; Alhuzali AF; Alrashed H; Alrodiman YA; Alim B Rhinology; 2023 Dec; 61(6):498-507. PubMed ID: 37772881 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19. Steffens Y; Le Bon SD; Lechien J; Prunier L; Rodriguez A; Saussez S; Horoi M Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5951-5953. PubMed ID: 35904632 [TBL] [Abstract][Full Text] [Related]
7. Injection of Platelet Rich Plasma in the Olfactory Cleft for COVID-19 Patients With Persistent Olfactory Dysfunction: Description of the Technique. Lechien JR; Saussez S Ear Nose Throat J; 2024 Jun; 103(1_suppl):115S-119S. PubMed ID: 36219733 [TBL] [Abstract][Full Text] [Related]
8. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study. Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial. Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024 [TBL] [Abstract][Full Text] [Related]
10. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic. Liu DT; Prem B; Besser G; Renner B; Mueller CA Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356 [TBL] [Abstract][Full Text] [Related]
12. Stellate ganglion block for treating post-COVID-19 parosmia. Naimi BR; Garvey E; Chandna M; Duffy A; Hunter SR; Mandloi S; Kahn C; Farquhar D; D'Souza G; Rabinowitz M; Rosen M; Toskala E; Roedl JB; Zoga A; Nyquist G; Rosen D Int Forum Allergy Rhinol; 2024 Jun; 14(6):1088-1096. PubMed ID: 38226898 [TBL] [Abstract][Full Text] [Related]
13. Omega-3 Fatty Acid Supplementation for the Treatment of Persistent COVID-Related Olfactory Dysfunction. Lerner DK; Garvey KL; Arrighi-Allisan A; Kominsky E; Filimonov A; Al-Awady A; Filip P; Liu K; Ninan S; Spock T; Tweel B; van Gerwen M; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM Am J Rhinol Allergy; 2023 Sep; 37(5):531-540. PubMed ID: 37261995 [TBL] [Abstract][Full Text] [Related]
14. Platelet-Rich Plasma (PRP) in the Treatment of Long COVID Olfactory Disorders: A Comprehensive Review. Maniaci A; Lavalle S; Masiello E; Lechien JR; Vaira L; Boscolo-Rizzo P; Musa M; Gagliano C; Zeppieri M Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672163 [No Abstract] [Full Text] [Related]
15. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer. Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617 [TBL] [Abstract][Full Text] [Related]
16. Depression Symptoms and Olfactory-related Quality of Life. Liu DT; Prem B; Sharma G; Kaiser J; Besser G; Mueller CA Laryngoscope; 2022 Sep; 132(9):1829-1834. PubMed ID: 35353380 [TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial. Singh SK; Kumar V; Rai T Indian J Dermatol Venereol Leprol; 2020; 86(2):150-157. PubMed ID: 31823902 [TBL] [Abstract][Full Text] [Related]
19. No Benefit to Platelet-rich Plasma Over Placebo Injections in Terms of Pain or Function in Patients with Hemophilic Knee Arthritis: A Randomized Trial. Duan W; Su X; Yu Z; Jiang M; Zhao L; Giannoudis PV; Guo JJ Clin Orthop Relat Res; 2022 Dec; 480(12):2361-2370. PubMed ID: 35638918 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of platelet-rich plasma in long-lasting post-viral olfactory dysfunction: a case-series. Lechien JR; Saussez S Eur Arch Otorhinolaryngol; 2024 Nov; 281(11):5841-5846. PubMed ID: 38992193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]